EXPLORATION OF THE HUMAN ADENOVIRUS PROTEASE ACTIVATION PATHWAY VIA LONG TIMESC
EXPLORATION OF THE HUMAN ADENOVIRUS PROTEASE ACTIVATION PATHWAY VIA LONG TIMESC
批准号:
8364351
负责人:
Ross Charles Walker
金额:
$0.11万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2013-07-31
关键词:
AdenovirusesAmino AcidsAntiviral AgentsBindingBiomedical ResearchCodeDevelopmentEnzymesExcisionFundingGrantHigh Performance ComputingHuman AdenovirusesInvestigationLocationMethodsMotionNational Center for Research ResourcesPathway interactionsPeptide HydrolasesPeptidesPrincipal InvestigatorResearchResearch InfrastructureResourcesRunningSeedsSignal Transduction PathwaySimulateSourceStructureTechniquesUnited States National Institutes of HealthVirus Replicationbasecofactorcostenzyme structuremolecular dynamicsnext generationsimulation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The adenovirus protease (AVP) is an enzyme essential for virus replication and hence is a target for antiviral drugs. The enzyme is activated upon the binding of a small peptide via a 53 amino acid signal transduction pathway. We have used simulated annealing based Nudged Elastic Band (NEB) techniques implemented within version 11 of the AMBER molecular dynamics code to predict low energy barrier activation pathways of AVP. Crystal structures obtained by the co-PI of both the inactivate and active forms of AVP provide the two end points of the activation pathway and the NEB code has been used to predict intermediates along this pathway. However, the NEB method necessarily places restrictions on the actual pathway. The simulation of unbiased activation pathways for AVP will provide critical information in the development of next generation antiviral drugs. We plan to run two 25 ¿s unbiased MD trajectories. The first starting from the inactive enzyme structure immediately after activation with the pVIc peptide cofactor and the other starting from the active enzyme structure immediately after the removal of the activating pVIc peptide cofactor. These simulations will provide critical information regarding motions along the activation pathway that will provide specific target locations for AVP inhibition and also provide seed structures for more in-depth NEB investigations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT AND APPLICATION OF ADVANCED MOLECULAR DYNAMICS ALGORITHMS AND ANALY
-
批准号:8364293
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2011
-
负责人:Ross Charles Walker
-
依托单位:
DEVELOPMENT AND APPLICATION OF ADVANCED MOLECULAR DYNAMICS ALGORITHMS AND ANALY
-
批准号:8171904
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2010
-
负责人:Ross Charles Walker
-
依托单位:
PORTING AND BENCHMARKING OF THE AMBER MOLECULAR DYNAMICS SOFTWARE ON TERAGRID R
-
批准号:7956259
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Ross Charles Walker
-
依托单位:
DEVELOPMENT AND APPLICATION OF ADVANCED MOLECULAR DYNAMICS ALGORITHMS AND ANALY
-
批准号:7956365
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Ross Charles Walker
-
依托单位:
PORTING AND BENCHMARKING OF THE AMBER MOLECULAR DYNAMICS SOFTWARE ON TERAGRID R
-
批准号:7723400
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Ross Charles Walker
-
依托单位:
海外基金